Drug Development for Vaccinia
$165,000Y01FY2010AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
This IAA supports the application of whole body bioimaging to the analysis of protection from vaccinia lethality conferred by antivirals.
View original record on NIH RePORTER →